Skip to content

Periodontal Management in Hypertensive Patients (PERIOTENSION Trial I)

Periodontal Management in Hypertensive Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04328389
Acronym
PERIOTENSION
Enrollment
100
Registered
2020-03-31
Start date
2024-06-30
Completion date
2024-12-31
Last updated
2021-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases, Gingivitis, Hypertension

Brief summary

Treated hypertensive patients with any form of periodontal diseases will be randomized to either supragingival dental plaque removal using electric toothbrushes at home or intensive professional oral hygiene treatment and the effects on blood pressure will be identified.

Interventions

Participants will be instructed to use their electric toothbrushes twice a day for controlling oral plaque

PROCEDUREProfessional oral hygiene

Professional oral hygiene using ultrosound scaling and root planing

Sponsors

University of L'Aquila
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
35 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Treated hypertension * Have at least 20 natural teeth * Presence of any form of periodontal diseases according to guidelines * Absence of other significant oral infections.

Exclusion criteria

* Secondary hypertension (known plasma renin screening, abdominal ultrasound with doppler and other investigations) * Individual is pregnant or nursing * Primary pulmonary hypertension * Professional oral hygine within past 6 months * Flu, rhinitis, sinusitis etc. within past 4 weeks * Use of antibiotics within past 4 weeks * Hospitalization for any reason within the past 3 months * Allergic disorders; History of chronic infectious disease, * Chronic hepatitis B or C infection * Chronic Obstructive Pulmonary Disease (COPD), tuberculosis * Other known chronic inflammatory or autoimmune condition such as lupus or rheumatoid arthritis, ulcerative colitis or Crohn's disease * Use of systemic or local steroids or immunosuppressive agents within 6 months of the inclusion. * History of alcohol abuse or unwillingness to limit alcohol consumption to less than 4 drinks per week

Design outcomes

Primary

MeasureTime frameDescription
Systolic and Diastolic Blood Pressure Change1 weekAmbulatory Blood Pressure Monitoring

Secondary

MeasureTime frameDescription
Systolic and Diastolic Blood Pressure Change1 weekUnattented Blood Pressure Measurement

Other

MeasureTime frame
Periodontal Health Score - Bleeding on probing (BoP)1 week
Periodontal Health Score - Periodontal Probing Depth (PPD)1 week
Periodontal Health Score - Clinical Attachment Loss (CAL)1 week

Contacts

Primary ContactDavide Pietropaoli, DDS, PhD
davide.pietropaoli@univaq.it+39 0862 434974
Backup ContactRita Del Pinto, MD. PhD
rita.delpinto@univaq.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026